Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Lintzeris

Showing results (151-160 of 196) with videos related to

Pageof 20
Sort By:
European Addiction Research|March 18, 2024
Measuring Objective and Subjective Sleep during Lisdexamfetamine Treatment of Acute Methamphetamine Withdrawal: A Feasibility StudyLiam S Acheson, Christopher Gordon, Rebecca McKetin, et al.
Drug and Alcohol Review|May 11, 2018
An overview of take-home naloxone programs in AustraliaRobyn Dwyer, Anna Olsen, Carrie Fowlie, et al.
Lancet (London, England)|June 1, 2010
Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trialJohn Strang, Nicola Metrebian, Nicholas Lintzeris, et al.
British Journal of Clinical Pharmacology|December 28, 2020
Clinical correlates and outcomes associated with pregabalin use among people prescribed opioids for chronic non-cancer pain: A five-year prospective cohort studySuzanne Nielsen, Natasa Gisev, Janni Leung, et al.
Drug and Alcohol Dependence|November 18, 2022
Lisdexamfetamine for the treatment of acute methamphetamine withdrawal: A pilot feasibility and safety trialLiam S Acheson, Nadine Ezard, Nicholas Lintzeris, et al.
JAMA Network Open|May 10, 2021
Patient-Reported Outcomes of Treatment of Opioid Dependence With Weekly and Monthly Subcutaneous Depot vs Daily Sublingual Buprenorphine: A Randomized Clinical TrialNicholas Lintzeris, Adrian J Dunlop, Paul S Haber, et al.
Journal of Addiction Medicine|March 7, 2018
Transferring Patients From Methadone to Buprenorphine: The Feasibility and Evaluation of Practice GuidelinesNicholas Lintzeris, Lauren A Monds, Consuelo Rivas, et al.
BMC Pharmacology & Toxicology|March 21, 2014
Cohort protocol paper: the Pain and Opioids In Treatment (POINT) studyGabrielle Campbell, Richard Mattick, Raimondo Bruno, et al.
JAMA Network Open|April 9, 2021
Pharmaceutical Opioid Use Patterns and Indicators of Extramedical Use and Harm in Adults With Chronic Noncancer Pain, 2012-2018Louisa Degenhardt, Phillip Hungerford, Suzanne Nielsen, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 23, 2017
Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-AnalysisSuzanne Nielsen, Pamela Sabioni, Jose M Trigo, et al.
Pageof 20

Showing results (151-160 of 196) with videos related to

Sort By:
Pageof 20
European Addiction Research|March 18, 2024
Measuring Objective and Subjective Sleep during Lisdexamfetamine Treatment of Acute Methamphetamine Withdrawal: A Feasibility StudyLiam S Acheson, Christopher Gordon, Rebecca McKetin, et al.
Drug and Alcohol Review|May 11, 2018
An overview of take-home naloxone programs in AustraliaRobyn Dwyer, Anna Olsen, Carrie Fowlie, et al.
Lancet (London, England)|June 1, 2010
Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trialJohn Strang, Nicola Metrebian, Nicholas Lintzeris, et al.
British Journal of Clinical Pharmacology|December 28, 2020
Clinical correlates and outcomes associated with pregabalin use among people prescribed opioids for chronic non-cancer pain: A five-year prospective cohort studySuzanne Nielsen, Natasa Gisev, Janni Leung, et al.
Drug and Alcohol Dependence|November 18, 2022
Lisdexamfetamine for the treatment of acute methamphetamine withdrawal: A pilot feasibility and safety trialLiam S Acheson, Nadine Ezard, Nicholas Lintzeris, et al.
JAMA Network Open|May 10, 2021
Patient-Reported Outcomes of Treatment of Opioid Dependence With Weekly and Monthly Subcutaneous Depot vs Daily Sublingual Buprenorphine: A Randomized Clinical TrialNicholas Lintzeris, Adrian J Dunlop, Paul S Haber, et al.
Journal of Addiction Medicine|March 7, 2018
Transferring Patients From Methadone to Buprenorphine: The Feasibility and Evaluation of Practice GuidelinesNicholas Lintzeris, Lauren A Monds, Consuelo Rivas, et al.
BMC Pharmacology & Toxicology|March 21, 2014
Cohort protocol paper: the Pain and Opioids In Treatment (POINT) studyGabrielle Campbell, Richard Mattick, Raimondo Bruno, et al.
JAMA Network Open|April 9, 2021
Pharmaceutical Opioid Use Patterns and Indicators of Extramedical Use and Harm in Adults With Chronic Noncancer Pain, 2012-2018Louisa Degenhardt, Phillip Hungerford, Suzanne Nielsen, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 23, 2017
Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-AnalysisSuzanne Nielsen, Pamela Sabioni, Jose M Trigo, et al.
Pageof 20